University Hospital Plymouth NHS Trust
74
10
11
46
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
6.8%
5 terminated/withdrawn out of 74 trials
90.2%
+3.7% vs industry average
5%
4 trials in Phase 3/4
2%
1 of 46 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (74)
Volatile Organic Compound Assessment in Pancreatic Ductal Adenocarcinoma
Role: collaborator
5 Minute 'HOT' Trauma CT Rates Of Detection Study
Role: lead
Opinions, Perceptions, & Thoughts of British Resident Doctors on Orthopaedics
Role: lead
Virtual Group Prehabilitation Education (Surgery School) Feasibility Trial
Role: collaborator
Splenic Embolisation Decisions
Role: lead
Understanding Cauda Equina Syndrome
Role: collaborator
Quality of Life Improvement After TAVI (QualiTAVI-UK Trial)
Role: lead
I-FIGS Feasibility Study
Role: lead
The SToICAL Study - The Soft Tissue Injection of Corticosteroid And Local Anaesthetic Study
Role: lead
Patient Reported Outcomes, Postoperative Pain and Pain Relief After Day Case Surgery (POPPY)
Role: lead
Experience of Biologic Treatments for Severe Asthma: a Survey
Role: collaborator
Defining Core Outcomes and Data Elements (CODE) in Chronic Subdural Haematoma
Role: lead
Predicting Incidental Gallbladder Cancer
Role: lead
Volatile Organic Compounds as Breath Biomarkers in Squamous Oesophageal Neoplasms
Role: collaborator
Tolerance in Beekeepers
Role: lead
Ergonomic Challenges for Surgeons; The Problem and Solutions
Role: lead
Timing to Restart Direct Oral Anticoagulants After Traumatic Intracranial Haemorrhage
Role: collaborator
Study on Optimal Temperature During Cardiopulmonary Bypass (THERMIC-4)
Role: collaborator
Augmented Response of Volatile Biomarkers in Assessment of Oesophagogastric Cancer (AROMA 1 / BIORESOURCE)
Role: collaborator
A Combination of Rituximab and Varlilumab Immunotherapy in Patients with B-cell Lymphoma
Role: collaborator